Medpace Holdings (MEDP) Change in Account Payables (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Change in Account Payables came in at -$129000.0 in Q2 2026, down 109.92% YoY from $1.3 million in Q2 2025, and down 253.57% on a QoQ basis from $84000.0 in Q1 2026.
Medpace Holdings (MEDP) Change in Account Payables (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Change in Account Payables data on file, last reported at -$129000.0 in Q2 2026.
- Quarterly Change in Account Payables fell 109.92% year-over-year to -$129000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$9.4 million (down 182.0% YoY) and the FY2025 annual result came in at $2.6 million, up 188.67% from the prior year.
- Change in Account Payables slipped to -$129000.0 in Q2 2026, from $84000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $10.7 million in Q1 2025 to a low of -$10.7 million in Q3 2025.
- A 5-year average of $394500.0 and a median of $74000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 2093.31% — and 2025, when it tumbled 1761.98%.
- Tracing MEDP's Change in Account Payables over 5 years: stood at $5.7 million in 2022, then tumbled by 65.17% to $2.0 million in 2023, then plunged by 96.75% to $64000.0 in 2024, then surged by 1982.81% to $1.3 million in 2025, then tumbled by 109.68% to -$129000.0 in 2026.
- The last three Change in Account Payables figures came in at -$129000.0 (Q2 2026), $84000.0 (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -6.74 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 21.88 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 674,000.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | - |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | -129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -129,000.00 |
| Jun 30, 2026 | -129,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Mar 31, 2026 | 84,000.00 |
| Dec 31, 2025 | 1.33 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | -10.73 Mn |
| Sep 30, 2025 | -10.73 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 10.72 Mn |
| Mar 31, 2025 | 10.72 Mn |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | -576,000.00 |
| Sep 30, 2024 | -576,000.00 |
| Jun 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | -7.35 Mn |
| Mar 31, 2024 | -7.35 Mn |